Faquih, Tariq O.
Landstra, Elvire N.
van Hylckama Vlieg, Astrid
Aziz, N. Ahmad
Li-Gao, Ruifang
de Mutsert, Renée
Rosendaal, Frits R.
Noordam, Raymond
van Heemst, Diana
Mook-Kanamori, Dennis O.
van Dijk, Ko Willems
Breteler, Monique M. B. http://orcid.org/0000-0002-0626-9305
Funding for this research was provided by:
ZonMW-VENI (916.14.023)
Velux Stiftung (1156, 1156)
King Faisal Specialist Hospital and Research Centre (1012879283)
Deutsche Forschungsgemeinschaft (EXC2151-390873048)
SFB1454 (432325352)
Bundesministerium für Bildung und Forschung (01EA1410C, FKZ:01EA1809C)
PreBeDem - Mit Prävention und Behandlung gegen Demenz (FKZ: 01KX2230)
Helmholtz Association Initiative and Networking Fund (No. RA-285/19)
2023 Innovation Pool
Article History
Received: 28 June 2023
Revised: 15 November 2023
Accepted: 4 December 2023
First Online: 6 February 2024
Declarations
:
: R. Li-Gao is a part-time clinical research consultant for Metabolon, Inc. All other authors have no relevant financial or non-financial interests to declare.
: The NEO study was approved by the medical ethical committee of the Leiden University Medical Centre (LUMC) and all participants gave their written informed consent. The ethics committee of the medical faculty of the University of Bonn approved the undertaking of the Rhineland Study and it was carried out according to the recommendations of the International Council for Harmonisation Good Clinical Practice standards.
: Written informed consent was acquired from all participants per the Declaration of Helsinki in both the NEO and Rhineland Study.